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Skin fibroblasts were selected ashaving cytochrome-c oxidase deficiency by activity mesurements in whole cells. Each 
cell line was cultured in sufficient amount to isolate mitochondria for biochemical characterization. Cytochrome-c oxidase 
was then examined by activity measurements, by heme determination and by polypeptide analysis using antibodies pecif- 
ic to the enzyme subunits. The cytochrome-c ox&se activity in the different cell lines ranged from 9% to 54% of that 
of normal fibroblasts. Heme determinations and polypeptide analysis established that the lowered cytochrome-c oxidase 
activity was due to reduced amounts of the complex in the mitochondrial inner membrane. In all cases, there was defective 
assembly of the enzyme, with the amounts of mitochondrially coded and nuclear coded subunits being reduced propor- 
tionally. These studies show that fibroblasts can be used for prenatal diagnosis of mitochondrial diseases and are a useful 
system in which to study mitochondrial biogenesis. 
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1. INTRODUCTION 
Cytochrome-c oxidase, the terminal component 
of the respiratory chain, catalyzes the four electron 
reduction of molecular oxygen, coupling this to 
proton pumping across the mitochondrial inner 
membrane [1,2]. The mammalian enzyme has been 
found to consist of 13 different polypeptides [3,4], 
three of which are coded for by mtDNA [5], the re- 
mainder being encoded by nuclear DNA. It is the 
mitochondrially coded subunits which provide the 
catalytic core of cytochrome-c oxidase, as apopro- 
teins for the redox centers and including the redox 
linked proton pump [I ,2]. The nuclear coded sub- 
units of the enzyme appear to have a regulatory 
function [6,7]. 
Heme cytochrome-c oxidase deficiency has been 
described in a number of patients [g-10] and we 
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have shown that in certain cases the defect is 
demonstrable in cultured skin fibroblasts [ 1 l- 131. 
Here we describe a study of 13 different fibro- 
blast cell lines, all from patients with lac- 
ticacidemia associated with either Leigh syndrome, 
Kearns-Sayre syndrome or other generalized mito- 
chondrial myopathies. These were chosen because 
they showed cytochrome oxidase deficiency by ac- 
tivity measurements of whole cells. Mitochondria 
have been isolated from these cell lines and 
respiratory chain defects studied biochemically in 
fibroblasts for one of the first times (see also [lo] 
published after completion of our work). 
2. MATERIALS AND METHODS 
Cell lines used in this study were obtained by skin biopsy 
from patients, after informed consent. Fibroblasts were 
cultured in Eagle’s minimum essential medium and 10% fetal 
calf serum, supplemented with glucose to a concentration of 
10.5 mM. Mitochondria were isolated from confluent cultures 
of these cells by the method of Millis and Pious [14], omitting 
the use of protease. Cytochrome-c oxidase activity was assayed 
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in sonicated mitochondria by the method of DiMauro et al. [15] 
and in sonicated whole cell preparations by the method of 
Glerum et al. [16]. 
Immunoblotting was carried out using 1OOpg of fibroblast 
mitochondrial protein. Samples were separated on 6 M 
urea/l6% SDS polyacrylamide gels (modified from Kadenbach 
et al. [17]) and electroblotted onto nitrocellulose by the method 
of Towbin et al. [18], with the addition of 0.1% SDS to the elec- 
trode buffer. The electroblotted nitrocellulose sheets were then 
blocked with 3% gelatin-TBS (20 mM Tris, 0.5 M NaCI, 
pH 7.5) for 1 h, followed by an overnight incubation in 
primary antibody. Incubation in secondary antibody was for 
3 h, using affinity-purified goat anti-rabbit IgG-horseradish 
peroxidase conjugate (Bio-Rad). The subunit specific anti- 
bodies used were to Mtn and CIV (nomenclature of Takamiya 
et al. [19]), and to the core proteins of complex III. The anti- 
bodies were raised to the purified subunits of the bovine heart 
enzyme. 
Heme concentrations were determined from oxidized minus 
dithionite reduced spectra, in a Beckman DU-7 spectrophoto- 
meter. Mitochondrial preparations were used at a concentration 
of at least 3 mg/ml of protein, suspended in a 100 mM 
potassium phosphate buffer, pH 7.4, containing 1% Triton 
X-100. The concentrations were calculated using the extinction 
coefficients of Bookelman et al. [20] and protein was deter- 
mined by the method of Lowry et al. [21]. 
3. RESULTS 
3.1. Electron transfer activities in cultured skin 
fibroblasts 
Control fibroblasts (taken from subjects without 
identified metabolic disturbances) proved to, have 
lower electron transfer activities than found in 
other tissues. For example, the rotenone-sensitive 
NADH-cytochrome c reductase activity was 
53 nmol . min-’ - mg-’ and cytochrome-c oxidase 
activity 40 nmol e min-’ . mg-‘, compared with 
values of 130 nmol . min-’ . mg-’ and 900 nmol . 
min-’ . mg-‘, respectively, for these two activities 
in human skeletal muscle [22]. This low content of 
cytochrome-c oxidase in fibroblasts was confirmed 
by determination of heme a. The heme a content of 
control fibroblasts was 21 pmol/mg mitochondrial 
protein, compared with values of around 
500 pmol/mg in human skeletal muscle [22]. The 
ratio of cytochromes b, cl and aa in fibroblasts 
calculated from heme determinations was 
2.5 : 2.5 : 1 (cf. 1: 2: 2 in human skeletal muscle). 
3.2. Studies of mutant fibroblasts 
Cultured skin fibroblasts from patients with lac- 
ticacidemia were screened initially for respiratory 
chain defects by measuring lactate to pyruvate 
ratios as an indicator of intracellular redox state. 
Respiratory chain defects were then confirmed by 
activity measurements on cell cultures. 
Eleven patient cell lines with normal NADH and 
succinate cytochrome c reductase activities but 
with decreased cytochrome-c oxidase activity as 
measured in whole cells were chosen for further 
study. These are listed in table 1. Two other cell 
lines were examined because they displayed con- 
sistently decreased activity of cytochrome-c ox- 
idase, though their lactate to pyruvate ratios were 
only slightly above normal. Activities of cyto- 
chrome-c oxidase varied from 9 to 56% of the ac- 
tivity determined in control cell lines. Electron 
microscopic examination of the deficient cells 
revealed no abnormality of mitochondrial ultra- 
structure. Further analysis was carried out using 
mitochondria isolated from these skin fibroblasts. 
3.3. Heme determinations 
Visible spectra in the a-band region and in the 
Soret region for two of the cell lines deficient in 
cytochrome-c oxidase activity are shown in fig. 1, 
along with the spectrum of a control fibroblast cell 
line. The amount of cytochrome aa in relation to 
cytochromes b and c is significantly smaller in 
both, and is approximately proportional to the 
amount of cytochrome-c oxidase activity measured 
for these two cell lines. Thus in cell line 2417, there 
was no detectable au3 either by absorbance in the 
Cell line 
Control 1685 
Partial defect 
1630 
1947 
2130 
2233 
2440 
Severe defect 
890 
1489 
1909 
2161 
2246 
2288 
2417 
2434 
Table 1 
Cell lines used in this study 
Activity (%) 
100 
56 
50 
41 
45 
46 
24 
27 
19 
17 
25 
30 
9 
12 
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Fig.1. Reduced minus oxidized optical difference spectra of 
mitochondrial samples from cultured skin fibroblasts. Cell line 
1685 is a control cell line. Cell lines 2417 and 2440 are from pa- 
tients with Leigh’s syndrome. Samples were reduced with 
sodium dithionite. 
a-band region or in the Soret at 442 nm. This cell 
line shows only 9% normal cytochrome-c oxidase 
activity. Cell line 2440 shows a small peak for au3 
at 605 nm and a shoulder at 442 nm in the Soret 
region, consistent with a small amount of cyto- 
chrome-c oxidase being present. This cell line 
shows 40% of normal cytochrome-c oxidase ac- 
tivity. 
Table 2 summarizes the cytochrome-c oxidase 
activities and heme determinations for several dif- 
ferent cell lines. 
3.4. Polypeptide analysis 
A typical immunoblotting experiment in which 
cell lines were tested for the presence of cyto- 
chrome-c oxidase subunits is shown in fig.2. Anti- 
bodies against subunits Mtn and CIV [ 191 were used 
to monitor the relative concentrations of the mito- 
chondrially and nuclear coded subunits, respec- 
tively. As an internal control, antibodies against 
the core proteins of complex III were included. 
Each lane contains 100,~g of mitochondrial pro- 
tein from a different cell line. It can be seen that 
the labelling by core protein antibody is, relatively, 
the same in each lane, confirming the activity 
measurements in showing that the various cell lines 
have normal amounts of complex III. The 
amounts of both subunits Mtn and CIV were 
diminished in the cytochrome-c oxidase deficient 
cell lines, roughly in proportion to the amount of 
enzyme indicated to be present from activity and 
heme determinations. Thus cell line 1630 has ap- 
proximately half the amount of subunits Mtn and 
Crv and 50% activity, while cell line 2161, with on 
ly 20% normal activity has barely detectable 
amounts of the two cytochrome-c oxidase sub- 
units. Likewise, lines 1489, 1947, 2130, 2233, 2288 
and 2440 have decreased amounts of protein and 
30-50% activity of cytochrome-c oxidase, whereas 
lines 890, 1909, 2246, 2417 and 2434 have very lit- 
tle if any detectable protein and cytochrome-c ox- 
idase activities ranging from 25% down to 9%. It 
is interesting to note that antibody to subunit Mtn 
Table 2 
Cytochrome-c oxidase activity and heme content of fibroblast cell lines 
Cell line Activity Heme content 
(nmol/min per mg mitochondrial protein) (pmol/mg mitochondrial protein) 
b Cl au3 bcl:aa3 
Control 
Def. 1630 
2417 
2440 
1909 
40.8 + 4.9 (7)= 57 54 21 5:l 
4.3 f 0.5 (5)b 
23.6 + 4.1 (6)” 77 53 16 8:l 
0.4 f 0.2 (5)b 89 91 undetectable - 
2.1 + 0.3 (5)b 76 57 11 12.1 
7.7 + 1.2 (9)” 25 21 undetectable - 
a Determined in mitochondria 
b Determined in whole cell extracts 
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Fig.2. Immunoblots of mitochondrial samples from cultured 
skin fibroblasts. The cell lines being examined are (lanes): (1) 
2233; (2) 2161; (3) 1630; (4) control cell line 1685. Band C is for 
the core proteins of complex III. Mtn and Cry are subunits of 
cytochrome-c oxidase. 
reacts nonspecifically in fibroblasts with proteins 
of M, = 30 000 and 11000, respectively. This cross- 
reactivity has not been seen in immunological 
studies of other human tissues [22]. 
4. DISCUSSION 
Fibroblasts constitutively have few mitochon- 
dria and are cultured in vitro, using glycolysis as 
the major energy-generating pathway. The spectral 
data presented here show that the heme concentra- 
tions in fibroblast mitochondria are low compared 
with most other mammalian tissue types and that 
the amount of cytochrome-c oxidase relative to 
complex III is also lower, i.e. 1: 5 compared with 
1: 2 in human skeletal muscle [22] and 2 : 1 in heart 
v31. 
Our data demonstrate that fibroblasts from a 
number of patients with lacticacidemia have a very 
low cytochrome-c oxidase content by activity, by 
the low amount of heme aa3 present and by a 
reduced amount of titratable subunits in the im- 
munoblotting experiments. In all of the cell lines 
reported here, the respiratory chain defect is 
localized to complex IV or cytochrome-c oxidase, 
and the amount of complex III (based on activities, 
heme determinations and immunoblotting with 
core protein antibody) as well as complexes I and 
II appears to be normal. Complexes I and III, like 
cytochrome-c oxidase, have both mitochondrially 
synthesized and nuclear coded subunits [23-251. 
It has been established that there is a sequential 
assembly of cytochrome-c oxidase in rat liver mito- 
chondria [26], and that a nucelar coded subunit is 
integral to this process. It has been shown by 
Wright et al. [27] that for the yeast enzyme, a dele- 
tion of the gene for subunit VIIa (corresponding to 
mammalian CIX) results in the loss of a functional 
cytochrome-c oxidase holoenzyme, and mutant 
cells lacking subunit VIIa also lack many other 
cytochrome-c oxidase subunits. It has also been 
proposed that mitochondria possess a groEL-type 
protein responsible for refolding of newly im- 
ported proteins [28] which could also be important 
in the assembly of cytochrome oxidase. 
Thus, the possibility exists that in the cell lines 
with reduced titratable cytochrome-c oxidase that 
there could be a mutation present which either (i) 
involves a gene encoding a mitochondrially syn- 
thesized subunit of complex IV, (ii) involves a gene 
encoding a subunit of complex IV synthesized in 
the cytoplasm or (iii) involves a gene encoding a 
structural or regulatory protein which is essential 
for the assembly of complex IV. The fact that the 
mode of inheritance for all these cases appears to 
be autosomal recessive makes the first possibility 
unlikely, but the exact site of the primary mutation 
is as yet obscure. 
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